BRAF and melanoma: Conversely, despite having an adequate reading depth, small-sized panels are applicable mainly in scenarios where the genomic regions of interest are known or anticipated (eg, BRAF mutation in BRAF mutant melanomas) but are not comprehensive enough to be useful in an unselected scenario.